Table 2.
Patient Presentation and Workup. a
| Characteristic | Total | Pre–COVID-19 | COVID-19 | P Value |
|---|---|---|---|---|
| Total number | 137 | 77 | 60 | |
| Tumor subsite | ||||
| Oral cavity | 57 (41.6) | 31 (40.3) | 26 (43.3) | .467 |
| Oropharynx | 51 (37.2) | 30 (38.9) | 21 (35.0) | |
| Sinonasal | 12 (8.8) | 9 (11.7) | 3 (5.0) | |
| Laryngeal | 15 (10.9) | 6 (7.8) | 9 (15.0) | |
| Other | 2 (1.5) | 1 (1.3) | 1 (1.7) | |
| Duration of symptoms prior to first visit, median (range), wk | 16 (0-261) | 19 (2-261) | 16 (0-120) | .483 |
| Duration from diagnosis to first visit, median (range), d | 27 (0-193) | 25 (0-185) | 27 (0-193) | .938 |
| Tumor (T) classification | ||||
| Tx | 6 (4.4) | 4 (5.2) | 2 (3.3) | .154 |
| T1 | 28 (20.4) | 18 (23.4) | 10 (16.7) | |
| T2 | 35 (25.6) | 24 (31.2) | 11 (18.3) | |
| T3 | 28 (20.4) | 14 (18.2) | 14 (23.3) | |
| T4 | 40 (29.2) | 17 (22.0) | 23 (38.3) | |
| Nodal (N) classification | ||||
| N0 | 54 (39.4) | 30 (38.9) | 24 (40.0) | .483 |
| N1 | 42 (30.7) | 27 (35.1) | 15 (25.0) | |
| N2 | 31 (22.6) | 16 (20.8) | 15 (25.0) | |
| N3 | 10 (7.3) | 4 (5.3) | 6 (10.0) | |
| Metastasis (M) classification | ||||
| M0 | 134 (97.8) | 76 (98.7) | 58 (96.7) | .419 |
| M1 | 3 (2.2) | 1 (1.3) | 2 (3.3) | |
| Size of primary tumor, longest dimension, median (range), cm | 3.5 (0.3-9.5) | 3.0 (0.3-6.9) | 4.5 (0.3-9.5) | .0002 |
| Size of largest nodal metastasis, longest dimension, median (range), cm | 2.1 (0.4-9.0) | 2.1 (0.6-7.0) | 2.1 (0.4-9.0) | .780 |
Abbreviation: COVID-19, coronavirus disease 2019.
a
Values are presented as number (%) unless otherwise indicated. Bold signifies that it met our significance threshold of P < 0.05.